Literature DB >> 28987261

Wilson Disease: Diagnosis, Treatment, and Follow-up.

Michael L Schilsky1.   

Abstract

Consideration of a diagnosis of Wilson disease is still the critical factor in testing for and establishing disease diagnosis. In association with other clinical and biochemical tests, liver biopsy results and molecular genetic testing can also be used to generate a score for diagnosing Wilson disease. Medical therapy is effective for most patients; liver transplant can rescue those with acute liver failure or those with advanced liver disease who fail to respond to or discontinue medical therapy. Treatment monitoring must be done at regular intervals and includes clinical evaluation, liver tests and blood counts, and copper metabolic parameters.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ceruloplasmin; Copper; Liver failure; Wilson disease

Mesh:

Substances:

Year:  2017        PMID: 28987261     DOI: 10.1016/j.cld.2017.06.011

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  18 in total

Review 1.  Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Authors:  Sabine Weiskirchen; Philipp Kim; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2019-04

2.  Presentations of Wilson Disease.

Authors:  Michael Schilsky
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-11

3.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

4.  Quality of Life of Patients with Wilson's Disease and Their Families.

Authors:  Ojas Unavane; Kritika Tiwari; Aabha Nagral; Ritika Aggarwal; Nikita Garg; Nishtha Nagral; Bela Verma; Ajay Jhaveri; Maninder S Setia
Journal:  J Clin Exp Hepatol       Date:  2021-06-09

5.  Diagnostic Value of a Modified Version of Wilson's Diagnostic Score in Pediatrics.

Authors:  S Sajedianfard; M Ataollahi; S M Dehghani
Journal:  Int J Organ Transplant Med       Date:  2020

6.  p.P1379S, a benign variant with reduced ATP7B protein level in Wilson Disease.

Authors:  Fan Yi; Sheri A Poskanzer; Candace T Myers; Jenny Thies; Christopher J Collins; Remwilyn Dayuha; Phi Duong; Roderick Houwen; Si Houn Hahn
Journal:  JIMD Rep       Date:  2020-05-19

7.  CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences.

Authors:  Ekaterina Y Ilyechova; Elisa Bonaldi; Iurii A Orlov; Ekaterina A Skomorokhova; Ludmila V Puchkova; Massimo Broggini
Journal:  Cells       Date:  2019-04-06       Impact factor: 6.600

8.  Case of Early-Onset Parkinson's Disease in a Heterozygous Mutation Carrier of the ATP7B Gene.

Authors:  Ekaterina Y Ilyechova; Irina V Miliukhina; Marina N Karpenko; Iurii A Orlov; Ludmila V Puchkova; Sergey A Samsonov
Journal:  J Pers Med       Date:  2019-08-17

9.  The study of Wilson disease in pregnancy management.

Authors:  Xu-En Yu; Min Pan; Yong-Zhu Han; Ren-Min Yang; Juan Wang; Shan Gao
Journal:  BMC Pregnancy Childbirth       Date:  2019-12-26       Impact factor: 3.007

10.  The co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysis.

Authors:  Sheri A Poskanzer; Jenny Thies; Christopher J Collins; Candace T Myers; Remwilyn Dayuha; Phi Duong; Fan Yi; Irene J Chang; Hans D Ochs; Troy R Torgerson; Si Houn Hahn
Journal:  Mol Genet Genomic Med       Date:  2020-02-17       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.